Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: To investigate longitudinal associations between polypharmacy and cognitive and physical capability and to determine whether these associations differ with cumulative exposure to polypharmacy. Design: Prospective birth cohort study. Setting: England, Scotland, and Wales. Participants: An eligible sample of men and women from the Medical Research Council National Survey of Health and Development with medication data at age 69 (N=2,122, 79%). Measurements: Cognitive capability was assessed using a word learning test, visual search speed task, and the Addenbrooke's Cognitive Examination, Third Edition (ACE‐III). Physical capability was measured using chair rise speed, standing balance time, walking speed, and grip strength. Results: Polypharmacy (5–8 prescribed medications) was present in 18.2% of participants at age 69 and excessive polypharmacy (≥9 prescribed medications) in 4.7%. Both were associated with poorer cognitive and physical capability in models adjusted for sex, education, and disease burden. Stronger associations were found for excessive polypharmacy (e.g., difference in mean ACE‐III scores comparing polypharmacy=−2.0, 95% CI=−2.8 to −1.1 and excessive polypharmacy=−2.9, 95% CI=−4.4 to −1.4 with no polypharmacy). Participants with polypharmacy at age 60 to 64 and at age 69 showed stronger Negative associations with cognitive and physical capability were stronger still in participants with polypharmacy at both age 60 to 64 and at age 69 (e.g. difference in mean chair rise speed, comparing polypharmacy with no polypharmacy at both ages=−3.9, 95% CI=−5.2 to −2.6 and at age 60–64 only=−2.5, 95% CI=−4.1 to −0.9). Conclusion: Polypharmacy at age 60 to 64 and age 69 was associated with poorer physical and cognitive capability, even after adjusting for disease burden. Stronger negative associations were seen in participants with longstanding polypharmacy, suggesting a cumulative, dose‐dependent relationship (where dose is the number of prescribed medications). Future research aiming to improve cognitive and physical capability should consider interventions to reduce the duration and level of polypharmacy at younger ages, in addition to optimizing disease control with appropriate medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia
Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000) · Neurology · doi:10.1212/01.wnl.0000434309.85312.19 · Cited by 1,029 · cited 1×
“The Addenbrooke’s Cognitive Examination, Third Edition (ACE-III) was also administered; this is a cognitive screening battery designed to detect risk of Alzheimer’s disease and cognitive impairment that is commonly used in clinical practice.(13) It is scored across varying cognitive subdomains, with a maximum score of…”
MethodJyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2116 · Cited by 417
Lifetime Socioeconomic Inequalities in Physical and Cognitive Aging
Hurst, L., Stafford, M., Cooper, R., Hardy, R., Richards, M., & Kuh, D. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301240 · Cited by 108 · cited 2×
“For all 4 variables, participants unable to complete the tests for health reasons (n599 for chair rise speed, n534 for maximum walk speed, n5111 for standing balance, n524 for grip strength) were assigned a score equal to the mean of the sex-specific lowest fifth for each measure, consistent with prior work in the NSH…”
ResultSelf-citation
Cited by
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
“In another study investigating the associations between polypharmacy and cognitive and physical capability, polypharmacy and longstanding polypharmacy were associated with poorer cognitive capability; an even stronger negative association was observed in individuals with longstanding polypharmacy [85].”
BackgroundIzquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
The C factor: cognitive dysfunction as a transdiagnostic dimension in psychopathology
Abramovitch, A., Short, T., & Schweiger, A. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102007 · Cited by 269
“Importantly, ample evidence indicates that the degree of cognitive deficiencies from polypharmacy exceed those due to monotherapy (Elie et al., 2010; Rawle, Cooper, Kuh, & Richards, 2018).”
BackgroundIbrahim, K., Cox, N. J., Stevenson, J. M., Lim, S., Fraser, S. D. S., & Roberts, H. C. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02208-8 · Cited by 266
Metadata
- Authors
- Rawle, M. J., Cooper, R., Kuh, D., & Richards, M.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2018-03-24
- Volume
- 66
- Issue
- 5
- Pages
- 916-923
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2791986960
- Cited by
- 145
- References
- 3
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. https://app.cochat.ai/papers/10.1111/jgs.15317
- The paper
- Rawle, M. J., Cooper, R., Kuh, D., & Richards, M. (2018). Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.15317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.